Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice

Am J Physiol Endocrinol Metab. 2000 Oct;279(4):E838-45. doi: 10.1152/ajpendo.2000.279.4.E838.

Abstract

Exposure to high-fat diets for prolonged periods results in positive energy balance and obesity, but little is known about the initial physiological and neuroendocrine response of obesity-susceptible strains to high-fat feeding. To assess responses of C57BL/6J mice to high- and low-fat diets, we quantitated the hypothalamic expression of neuropeptides implicated in weight regulation and neuroendocrine function over a 2-wk period. Exposure to high-fat diet increased food consumption over a 2-day period during which leptin levels were increased when assessed by a frequent sampling protocol [area under the curve (AUC): 134.6 +/- 10.3 vs. 100 +/- 12.3, P = 0.03 during first day and 126.5 +/- 8.2 vs. 100 +/- 5.2, P = 0.02 during second day]. During this period, hypothalamic expression of neuropeptide Y (NPY) and agouti-related protein (AgRP) decreased by approximately 30 and 50%, respectively (P < 0.001). After 1 wk, both caloric intake and hypothalamic expression of NPY and AgRP returned toward baseline. After 2 wk, cumulative caloric intake was again higher in the high-fat group, and now proopiomelanocortin (POMC) was elevated by 76% (P = 0.01). This study demonstrates that high-fat feeding induces hyperphagia, hyperleptinemia, and transient suppression of orexigenic neuropeptides during the first 2 days of diet. The subsequent induction of POMC may be a second defense against obesity. Attempts to understand the hypothalamic response to high-fat feeding must examine the changes as they develop over time.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Agouti-Related Protein
  • Animals
  • Area Under Curve
  • Body Composition / drug effects
  • Body Weight / drug effects
  • Corticosterone / blood
  • Dietary Fats / pharmacology*
  • Eating / drug effects
  • Energy Intake / drug effects
  • Fatty Acids, Nonesterified / blood
  • Hypothalamus / metabolism*
  • Insulin / blood
  • Intercellular Signaling Peptides and Proteins
  • Leptin / blood
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuropeptide Y / biosynthesis
  • Neuropeptide Y / genetics
  • Neuropeptides / biosynthesis*
  • Neuropeptides / genetics
  • Obesity / etiology
  • Obesity / metabolism*
  • Pro-Opiomelanocortin / biosynthesis
  • Pro-Opiomelanocortin / genetics
  • Protein Biosynthesis
  • Proteins / genetics
  • RNA, Messenger / biosynthesis
  • Repressor Proteins*
  • Suppressor of Cytokine Signaling 3 Protein
  • Suppressor of Cytokine Signaling Proteins
  • Transcription Factors*

Substances

  • Agouti-Related Protein
  • Agrp protein, mouse
  • Dietary Fats
  • Fatty Acids, Nonesterified
  • Insulin
  • Intercellular Signaling Peptides and Proteins
  • Leptin
  • Neuropeptide Y
  • Neuropeptides
  • Proteins
  • RNA, Messenger
  • Repressor Proteins
  • Socs3 protein, mouse
  • Suppressor of Cytokine Signaling 3 Protein
  • Suppressor of Cytokine Signaling Proteins
  • Transcription Factors
  • Pro-Opiomelanocortin
  • Corticosterone